ADAM RUDASILL: Open Payments
NPI 1720757149 · MIDDLEBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,409 in 73 payments from 20 companies in 2025. Trend: 2023 $1,858 · 2024 $1,667 · 2025 $1,409
Food & beverage: $1,409
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $284 |
| ABBVIE INC. | 18 | $249 |
| Novo Nordisk Inc | 13 | $243 |
| Lilly USA, LLC | 5 | $86 |
| Exact Sciences Corporation | 3 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Amgen Inc. | 5 | $75 |
| Dexcom, Inc. | 3 | $65 |
| HARMONY BIOSCIENCES LLC | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: FARXIGA, Ozempic, VRAYLAR, AIRSUPRA, MOUNJARO, Cologuard Collection Kit, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
